Page last updated: 2024-10-26

racemetirosine and Cognition Disorders

racemetirosine has been researched along with Cognition Disorders in 1 studies

alpha-Methyltyrosine: An inhibitor of the enzyme TYROSINE 3-MONOOXYGENASE, and consequently of the synthesis of catecholamines. It is used to control the symptoms of excessive sympathetic stimulation in patients with PHEOCHROMOCYTOMA. (Martindale, The Extra Pharmacopoeia, 30th ed)

Cognition Disorders: Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment.

Research Excerpts

ExcerptRelevanceReference
"In haloperidol-induced catalepsy in rats (1."5.30Effects of N-propargyl-1-(R)aminoindan (rasagiline) in models of motor and cognition disorders. ( Cohen, S; Levy, R; Speiser, Z, 1998)
"In haloperidol-induced catalepsy in rats (1."1.30Effects of N-propargyl-1-(R)aminoindan (rasagiline) in models of motor and cognition disorders. ( Cohen, S; Levy, R; Speiser, Z, 1998)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Speiser, Z1
Levy, R1
Cohen, S1

Other Studies

1 other study available for racemetirosine and Cognition Disorders

ArticleYear
Effects of N-propargyl-1-(R)aminoindan (rasagiline) in models of motor and cognition disorders.
    Journal of neural transmission. Supplementum, 1998, Volume: 52

    Topics: Aging; alpha-Methyltyrosine; Animals; Avoidance Learning; Catalepsy; Cognition; Cognition Disorders;

1998